STING agonist delivery by lipid calcium phosphate nanoparticles enhances immune activation for neuroblastoma

Neuroblastoma (NB) is a common solid tumor in children and infants, the formation and regression of which is closely linked to the tumor-host immune relationship. Stimulator of interferon genes (STING) agonists, particularly cyclic dinucleotide (CDN), have promising potential in NB therapy by genera...

Full description

Saved in:
Bibliographic Details
Main Authors: Bo Feng, Xiao Lu, Guangqin Zhang, Libo Zhao, Dong Mei
Format: Article
Language:English
Published: Compuscript Ltd 2023-05-01
Series:Acta Materia Medica
Online Access:https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2023-0011
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849430217719808000
author Bo Feng
Xiao Lu
Guangqin Zhang
Libo Zhao
Dong Mei
author_facet Bo Feng
Xiao Lu
Guangqin Zhang
Libo Zhao
Dong Mei
author_sort Bo Feng
collection DOAJ
description Neuroblastoma (NB) is a common solid tumor in children and infants, the formation and regression of which is closely linked to the tumor-host immune relationship. Stimulator of interferon genes (STING) agonists, particularly cyclic dinucleotide (CDN), have promising potential in NB therapy by generating innate and adaptive immune stimulation, thus leading to tumor control. CDN delivery in vivo is challenging due to the negative charge, hydrophilicity, and susceptibility to degradation by phosphodiesterase, which hinders the effectiveness of CDN. Thus, our study proposed four methods to load CDN into liposomes, using 2′,3′-cGAMP as the model drug. Lipid nanoparticles were prepared, followed by physicochemical characterization. Subsequently, cellular inhibition and immune stimulation were investigated. As a result, lipid calcium phosphate nanoparticles (LCP-NPs) possessed the highest encapsulation efficiency among the four preparation methods, with a diameter of 82.57±3.72 nm. LCP-NPs maintained size stability under refrigeration conditions at 4°C within 48 h. The surface of the liposome was positively charged. Compared to free cGAMP, LCP-NPs resulted in a slower release, enhanced cytotoxicity against tumor cells, greater activation of the cGAS-STING pathway, and increased expression of the immune factors. Taken together, these findings clearly demonstrated the effectiveness of the liposomal delivery system for cGAMP and provided a promising strategy for the treatment of NB.
format Article
id doaj-art-84bbb502a6494f87b0b3b017a1452ebb
institution Kabale University
issn 2737-7946
language English
publishDate 2023-05-01
publisher Compuscript Ltd
record_format Article
series Acta Materia Medica
spelling doaj-art-84bbb502a6494f87b0b3b017a1452ebb2025-08-20T03:28:05ZengCompuscript LtdActa Materia Medica2737-79462023-05-012221622710.15212/AMM-2023-0011STING agonist delivery by lipid calcium phosphate nanoparticles enhances immune activation for neuroblastomaBo FengXiao LuGuangqin ZhangLibo ZhaoDong MeiNeuroblastoma (NB) is a common solid tumor in children and infants, the formation and regression of which is closely linked to the tumor-host immune relationship. Stimulator of interferon genes (STING) agonists, particularly cyclic dinucleotide (CDN), have promising potential in NB therapy by generating innate and adaptive immune stimulation, thus leading to tumor control. CDN delivery in vivo is challenging due to the negative charge, hydrophilicity, and susceptibility to degradation by phosphodiesterase, which hinders the effectiveness of CDN. Thus, our study proposed four methods to load CDN into liposomes, using 2′,3′-cGAMP as the model drug. Lipid nanoparticles were prepared, followed by physicochemical characterization. Subsequently, cellular inhibition and immune stimulation were investigated. As a result, lipid calcium phosphate nanoparticles (LCP-NPs) possessed the highest encapsulation efficiency among the four preparation methods, with a diameter of 82.57±3.72 nm. LCP-NPs maintained size stability under refrigeration conditions at 4°C within 48 h. The surface of the liposome was positively charged. Compared to free cGAMP, LCP-NPs resulted in a slower release, enhanced cytotoxicity against tumor cells, greater activation of the cGAS-STING pathway, and increased expression of the immune factors. Taken together, these findings clearly demonstrated the effectiveness of the liposomal delivery system for cGAMP and provided a promising strategy for the treatment of NB.https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2023-0011
spellingShingle Bo Feng
Xiao Lu
Guangqin Zhang
Libo Zhao
Dong Mei
STING agonist delivery by lipid calcium phosphate nanoparticles enhances immune activation for neuroblastoma
Acta Materia Medica
title STING agonist delivery by lipid calcium phosphate nanoparticles enhances immune activation for neuroblastoma
title_full STING agonist delivery by lipid calcium phosphate nanoparticles enhances immune activation for neuroblastoma
title_fullStr STING agonist delivery by lipid calcium phosphate nanoparticles enhances immune activation for neuroblastoma
title_full_unstemmed STING agonist delivery by lipid calcium phosphate nanoparticles enhances immune activation for neuroblastoma
title_short STING agonist delivery by lipid calcium phosphate nanoparticles enhances immune activation for neuroblastoma
title_sort sting agonist delivery by lipid calcium phosphate nanoparticles enhances immune activation for neuroblastoma
url https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2023-0011
work_keys_str_mv AT bofeng stingagonistdeliverybylipidcalciumphosphatenanoparticlesenhancesimmuneactivationforneuroblastoma
AT xiaolu stingagonistdeliverybylipidcalciumphosphatenanoparticlesenhancesimmuneactivationforneuroblastoma
AT guangqinzhang stingagonistdeliverybylipidcalciumphosphatenanoparticlesenhancesimmuneactivationforneuroblastoma
AT libozhao stingagonistdeliverybylipidcalciumphosphatenanoparticlesenhancesimmuneactivationforneuroblastoma
AT dongmei stingagonistdeliverybylipidcalciumphosphatenanoparticlesenhancesimmuneactivationforneuroblastoma